Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Here we go friends! Have a great weekend! IPIX will triumph over all this troll talk. They let the science do the talking. Zero failed trials in 5 years
Do me a favor BOARD! B4 u read further and expand - imagine your on SHARK TANK: Now reread what this company is trying to accomplish in an untapped multi billion indication;
Summary Points
Brilacidin-OM viewed by Company to have significant competitive advantages and less challenges than other OM drug candidates:
Prevention: Effective reduction of SOM incidence, beyond providing symptom relief, would be a critical factor toward successful commercialization
Delivery: Brilacidin-OM developed in sachet packets offers a portable, quick-mixing, “instant” oral rinse therapy—patients and providers likely would more readily adopt
Cost: Brilacidin-OM avoids costly manufacturing and logistics of sterile IV therapy competitors amid a regulatory environment demanding lower drug prices
Company preparing for U.S. Food and Drug Administration (FDA) meeting to discuss Brilacidin-OM development plan
I will have another check by then. We are all good Dud. I’m more confident than ever. I’m just happy Scotty pointed out the P data change. Biotech is rarely on time. No argument there.
Green beer time
Great news and I concur. BP has made it clear to MGMT we are the leader in OM prevention.
Better news is that I will have an extra 7K soon. That is about 13000 more shares. Need about 2 weeks.
Cool thanks!
Recommend to Leo. Release a PR just like this and then mid day release the partnership news. That would CRUSH many
Right. They scream Leo has data. Lol. Ummmmm no he doesn’t. BAM
2 items: data is still blinded for P. The market for OM is larger than expected and if B-OM can gain approval as first PREVENTATIVE drug, it will be prescribed to EVERY PATIENT going through Chemo Rad.......$$$$$$
I mean. That is billions of dollars.
Otherwise, this PR has just a recap
In one PR....you will forgive him. Or actually......more likely your firm will go bankrupt.
54 k volume. Tight. Very tight
I invested in 2012ish. Here is what I've seen:
COMPARE FOR YOURSELF - 2012 to 2018 - IPIX $$$
September 31st 2012 - Closed at 1.00
In the 10-K released on 10/12/12 I found the below info. Here is link to 10-K (https://www.bamsec.com/filing/154823312000017?cik=1355250)
CASH ON HAND - $27,000
CTIX did not have any major Stock Purchase Agreements at the time! So no funds readily available.
OS as of SEPT 30th 2012 - - 93,124,151
They had ZERO CLINICAL trials - They were starting Kevetrin Phase 1 at the end of 2012 at Dana Farber Harvard and partners.
Some notes of accomplishments though:
Jan 2012 - Prurisol Patent Filed
March 2012 - BIDMC Agreement to test Keveterin
June 2012 - IND Meeting with FDA approved to seek section 505(b)(2)
June 2012 - IND approved by FDA to begin Phase 1 trial at Dana Farber and BIDMC for Keveterin
Sept 2012 - Selected Dr. Reddy's Lab to manufacturer P
COMPOUNDS OWNED BY CTIX in 2012: 8 TOTAL
Kevetrin
KM 133
KM 391
KM 277
KM 278
KM 362
KM-3174
KM-732
DESIGNATIONS: June 2012 for Prurisol - 505 (b)(2) Approach
_________________________________________________________________
FAST FORWARD ----- As of March 5th 2018 -----------
March 5th Close - .55
Total OS as of Jan 31st 2018 ----- 145,688,782 shares
Cash on hand: 3.2 Million
Financing in place: 25.6 MILLION available from ASPIRE
Financing in place: 75 Million Shelf Reg
Compounds Owned in 2018:
ADDITIONAL COMPOUNDS OWNED AFTER POLYMEDIX's acquisition: 18 TOTAL
**THIS INCLUDES PATENTS** It also included "SUBSTANTIAL EQUIPMENT ASSETS"
"We are very excited about instantly having a strong antibiotic franchise to complement our already robust pipeline that now contains 18 compounds"
ACCOMPLISHMENTS:
CLINICAL TRIALS: (Daubs summary)
1) PHASE I: A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors
(Start: Oct 2012 - End: Feb 2016) SUCCESSFUL
2) PHASE 2B: Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
(Start: Feb 2014 - END: Oct 2014) SUCCESSFUL
***Compared favorably to Daptomycin which is a blockbuster drug
3) PHASE I: Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers
(Start: March 2014 - End: Oct 2014) SUCCESFUL
4) PHASE II: Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
(Start: Aug 2015 - End: May 2016) SUCCESSFUL
5) PHASE 2B: Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
(Start: Oct 2016 - End: Dec 2017) TOP LINE DATA IN WEEKS
6) PHASE 2: Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer (Brilacidin)
(Start: May 2015 - End: Dec 2017) SUCCESSFUL
MGMT COMMENT:
There have been 4 PRs this year.
In 73 days. FYI. Major negotiations underway.
Deals are based off of:
Drug performance in trials
Market competition
Market Need
Manufacturing Cost
Number of interested parties can elevate the value due to competition
My belief is that a coordination of some very powerful news releases is in the works. That is what I believe.
Several of us made similar suggestions. No news please until a major announcement.
Lol. Costly and time consuming.....haha. Welcome to biotech! This is not developing websites bro
Boo birds are out in full effect today. IPIX - stay calm ;)
Leo is aware buddy. This won’t be a penny stock much longer and peeps that threaten Leo will be too cheap to hang around. Blue sky’s ahead!!!
I think and I’ve sent my opinion that the only news we see is concrete 8-K news.
Could be tomorrow or could be 3 weeks from now.
IPIX
The only 50’s coming is 50% PASI 75 at 400 mg. Boom. That would be a biologics killer
Hey! Did you see Blake’s contract extension!!$$$$$$. I’ll be Blake all day everyday!
Nice day here! My thoughts since seeing the certain posters here hitting so hard that past weeks and then really hard this week early is it was all manipulation and or air shares. And now back to where we started....... I feel bad for those who got juked and possibly lost their shares due to the financial terrorists.
Our day WILL come!
Phenomenal Post!
One More Time - I'll Post This For Free:
COMPARE FOR YOURSELF - 2012 to 2018 - IPIX $$$
AUGUST 31st 2012 - Closed at .63
September 31st 2012 - Closed at 1.00
In the 10-K released on 10/12/12 I found the below info. Here is link to 10-K (https://www.bamsec.com/filing/154823312000017?cik=1355250)
CASH ON HAND - $27,000
CTIX did not have any major Stock Purchase Agreements at the time! So no funds readily available.
OS as of SEPT 30th 2012 - - 93,124,151 (ABOUT 52 MILLION LESS than now)
They had ZERO CLINICAL trials - just pre-clinical work.
Some notes of accomplishments though:
Jan 2012 - Prurisol Patent Filed
March 2012 - BIDMC Agreement to test Keveterin
May 2012 - Jim Boeheim joined as advisor (lol) Jim is a good man but this was exciting at the time.
June 2012 - IND Meeting with FDA approved to seek section 505(b)(2)
June 2012 - IND approved by FDA to begin Phase 1 trial at Dana Farber and BIDMC for Keveterin
Sept 2012 - Selected Dr. Reddy's Lab to manufacturer P
COMPOUNDS OWNED BY CTIX in 2012: 8 TOTAL
Kevetrin
KM 133
KM 391
KM 277
KM 278
KM 362
KM-3174
KM-732
DESIGNATIONS: June 2012 for Prurisol - 505 (b)(2) Approach
_________________________________________________________________
FAST FORWARD ----- As of March 5th 2018 -----------
March 5th Close - .57
Total OS as of Jan 31st 2018 ----- 145,688,782 shares
Cash on hand: 3.2 Million
Financing in place: 25.6 MILLION available from ASPIRE
Financing in place: 75 Million Shelf Reg
Compounds Owned in 2018:
ADDITIONAL COMPOUNDS OWNED AFTER POLYMEDIX's acquisition: 18 TOTAL
**THIS INCLUDES PATENTS** It also included "SUBSTANTIAL EQUIPMENT ASSETS"
"We are very excited about instantly having a strong antibiotic franchise to complement our already robust pipeline that now contains 18 compounds"
ACCOMPLISHMENTS:
CLINICAL TRIALS: (Daubs summary)
1) PHASE I: A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors
(Start: Oct 2012 - End: Feb 2016) SUCCESSFUL
2) PHASE 2B: Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
(Start: Feb 2014 - END: Oct 2014) SUCCESSFUL
***Compared favorably to Daptomycin which is a blockbuster drug
3) PHASE I: Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers
(Start: March 2014 - End: Oct 2014) SUCCESFUL
4) PHASE II: Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
(Start: Aug 2015 - End: May 2016) SUCCESSFUL
5) PHASE 2B: Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
(Start: Oct 2016 - End: Dec 2017) TOP LINE DATA IN WEEKS
6) PHASE 2: Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer (Brilacidin)
(Start: May 2015 - End: Dec 2017) SUCCESSFUL
MGMT COMMENT:
There actually is no problem here. Just hedgies trying to force the weak and create fear. I’d assume there is some deep sh1t going on to see this many naysayers screaming fire in a crowded stadium.
Again. Concentrate on science and progress
I believe. I know of about 100K shares that have been bought this week by friends. They won’t sell anytime soon. Maybe once Kevetrin is sold or on market for several years.
Oh, by the way we are approaching March Madness!!! Gonna be great!
And 1 month from previous PR. For those that believe you need a 30 day quiet period prior to releasing partner news....we are 3days away - ha.
Silence is golden! Leo knows that.
If you have not already, revisit the PR several weeks ago discussing B and the anchor. They explain all the work they are putting in! CDA discussions, reformulation partnership negotiations, bulk production of B for instant market penetration. The little snippet on Insurance is telling. As you can recall that Leo has already met with top govt and senate officials to discuss B and healthcare costs.
He is light years ahead of where this board pegs him to be!
Stick with facts!
I would suggest in your scenario: hey, BP! Invest 15 million in open share purchases and watch your investment become billions as we work together to sell/market this blockbuster drug! Win win for you BP...since our share price is so artificially deflated at this point! Which I assume none of you BPs had any hand in.....you could basically pay for the drugs with your tiny investment upfront. ;).
That’s how the current share price could make BP a ton of cash!
Agree 100% on multiple partners in specific regions. Money could flow nicely from many different angles soon enough.
Not one NAYSAYER can hold a serious conversation or be disappointed with what IPIX has completed in my previous post!
All they can do is spread FUD and point to the share price——- which is easily manipulated. You can’t manipulate trial data or FDA designations - when IPIX moves to a later phase trial or moves to other formulations to move to more advanced trials....those things can’t be manipulated.
All the negative Nancy’s here have no bite to their posts. It’s simply the same crap that mako spewed : “no one in the office answering phones”. Lol. Haaaaaaaa. Good one.
Read my previous post. Those are facts. That is what has happened.
Haaaa! It’s successful. Read the PR.
FUD all day - facts are in writing. Keep trying
According to my FACTS, I'd say 8 SUCCESSFUL Clinical Trials with now 3 Approaching PHASE 3 - - - - I'd say we should be several times the 2012 1.00 share price!
Our time will come! IPIX has only succeeded!
GOOD INFO HERE!
COMPARE FACTS: HIGH AND DRY? I THINK NOT. LOOK WHAT LEO AND IPIX HAS ACCOMPLISHED IN 6 YEARS:
COMPARE FOR YOURSELF - 2012 to 2018 - IPIX $$$
AUGUST 31st 2012 - Closed at .63
September 31st 2012 - Closed at 1.00
In the 10-K released on 10/12/12 I found the below info. Here is link to 10-K (https://www.bamsec.com/filing/154823312000017?cik=1355250)
CASH ON HAND - $27,000
CTIX did not have any major Stock Purchase Agreements at the time! So no funds readily available.
OS as of SEPT 30th 2012 - - 93,124,151 (ABOUT 52 MILLION LESS than now)
They had ZERO CLINICAL trials - just pre-clinical work.
Some notes of accomplishments though:
Jan 2012 - Prurisol Patent Filed
March 2012 - BIDMC Agreement to test Keveterin
May 2012 - Jim Boeheim joined as advisor (lol) Jim is a good man but this was exciting at the time.
June 2012 - IND Meeting with FDA approved to seek section 505(b)(2)
June 2012 - IND approved by FDA to begin Phase 1 trial at Dana Farber and BIDMC for Keveterin
Sept 2012 - Selected Dr. Reddy's Lab to manufacturer P
COMPOUNDS OWNED BY CTIX in 2012: 8 TOTAL
Kevetrin
KM 133
KM 391
KM 277
KM 278
KM 362
KM-3174
KM-732
DESIGNATIONS: June 2012 for Prurisol - 505 (b)(2) Approach
_________________________________________________________________
FAST FORWARD ----- As of March 5th 2018 -----------
March 5th Close - .55
Total OS as of Jan 31st 2018 ----- 145,688,782 shares
Cash on hand: 3.2 Million
Financing in place: 25.6 MILLION available from ASPIRE
Financing in place: 75 Million Shelf Reg
Compounds Owned in 2018:
ADDITIONAL COMPOUNDS OWNED AFTER POLYMEDIX's acquisition: 18 TOTAL
**THIS INCLUDES PATENTS** It also included "SUBSTANTIAL EQUIPMENT ASSETS"
"We are very excited about instantly having a strong antibiotic franchise to complement our already robust pipeline that now contains 18 compounds"
ACCOMPLISHMENTS:
CLINICAL TRIALS: (Daubs summary)
1) PHASE I: A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors
(Start: Oct 2012 - End: Feb 2016) SUCCESSFUL
2) PHASE 2B: Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
(Start: Feb 2014 - END: Oct 2014) SUCCESSFUL
***Compared favorably to Daptomycin which is a blockbuster drug
3) PHASE I: Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers
(Start: March 2014 - End: Oct 2014) SUCCESFUL
4) PHASE II: Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
(Start: Aug 2015 - End: May 2016) SUCCESSFUL
5) PHASE 2B: Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
(Start: Oct 2016 - End: Dec 2017) TOP LINE DATA IN WEEKS
6) PHASE 2: Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer (Brilacidin)
(Start: May 2015 - End: Dec 2017) SUCCESSFUL
MGMT COMMENT:
COMPARE FOR YOURSELF - 2012 to 2018 - IPIX $$$
AUGUST 31st 2012 - Closed at .63
September 31st 2012 - Closed at 1.00
In the 10-K released on 10/12/12 I found the below info. Here is link to 10-K (https://www.bamsec.com/filing/154823312000017?cik=1355250)
CASH ON HAND - $27,000
CTIX did not have any major Stock Purchase Agreements at the time! So no funds readily available.
OS as of SEPT 30th 2012 - - 93,124,151 (ABOUT 52 MILLION LESS than now)
They had ZERO CLINICAL trials - just pre-clinical work.
Some notes of accomplishments though:
Jan 2012 - Prurisol Patent Filed
March 2012 - BIDMC Agreement to test Keveterin
May 2012 - Jim Boeheim joined as advisor (lol) Jim is a good man but this was exciting at the time.
June 2012 - IND Meeting with FDA approved to seek section 505(b)(2)
June 2012 - IND approved by FDA to begin Phase 1 trial at Dana Farber and BIDMC for Keveterin
Sept 2012 - Selected Dr. Reddy's Lab to manufacturer P
COMPOUNDS OWNED BY CTIX in 2012: 8 TOTAL
Kevetrin
KM 133
KM 391
KM 277
KM 278
KM 362
KM-3174
KM-732
DESIGNATIONS: June 2012 for Prurisol - 505 (b)(2) Approach
_________________________________________________________________
FAST FORWARD ----- As of March 5th 2018 -----------
March 5th Close - .55
Total OS as of Jan 31st 2018 ----- 145,688,782 shares
Cash on hand: 3.2 Million
Financing in place: 25.6 MILLION available from ASPIRE
Financing in place: 75 Million Shelf Reg
Compounds Owned in 2018:
ADDITIONAL COMPOUNDS OWNED AFTER POLYMEDIX's acquisition: 18 TOTAL
**THIS INCLUDES PATENTS** It also included "SUBSTANTIAL EQUIPMENT ASSETS"
"We are very excited about instantly having a strong antibiotic franchise to complement our already robust pipeline that now contains 18 compounds"
ACCOMPLISHMENTS:
CLINICAL TRIALS: (Daubs summary)
1) PHASE I: A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors
(Start: Oct 2012 - End: Feb 2016) SUCCESSFUL
2) PHASE 2B: Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
(Start: Feb 2014 - END: Oct 2014) SUCCESSFUL
***Compared favorably to Daptomycin which is a blockbuster drug
3) PHASE I: Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers
(Start: March 2014 - End: Oct 2014) SUCCESFUL
4) PHASE II: Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
(Start: Aug 2015 - End: May 2016) SUCCESSFUL
5) PHASE 2B: Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis
(Start: Oct 2016 - End: Dec 2017) TOP LINE DATA IN WEEKS
6) PHASE 2: Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer (Brilacidin)
(Start: May 2015 - End: Dec 2017) SUCCESSFUL
MGMT COMMENT:
They are working multiple license agreements. Just like the PR said. Working home turf and abroad. We may see a combo 1-2 punch soon.
More hands are raising to be called on. Ball is in IPIX court to decide.
I believe he will do what is best for IPIX and it’s loyal shareholders. He will not react to share price and manipulation because Leo controls when to tap aspire. Today is 100% manipulation not dilution, nor the result of “bad P results”. Data is not available.
This is comical over here. I asked the question and still have no answer: take share price out of it...what is concerning about IPIX and why are posters screaming bye bye IPIX?
I guess cats got a tongue or two.
The results are locked. So how do u know? Please explain!
Why so many negative posters over the past month? It’s like a gang.
Yet not one of you can explain a negative fact in regards to IPIX that has zero todo with share price.
So again, please give me a reason people are screaming bye bye to IPIX. What PR or what news has been issued in the past 2 months that is negative? There is only 3 PRs and not one is negative.
So if I agree with lily.
I’ll stop when we have bad results on 2 of the 3 drugs. We have perfection as of today. Therefore I added 18K more so far. Locked. Again. Share price means nothing. Share price can be manipulated, the science cannot. Follow what is real.
Ohhhh. That’s right, you can’t.
What’s wrong with IPIX and why bye bye? Please explain in detail with zero regards to share price. Ready go!
I’ll throw in an order here as well.